Literature DB >> 21078700

The immediate effects of diacutaneous fibrolysis on pain and mobility in patients suffering from painful shoulder: a randomized placebo-controlled pilot study.

M E Barra1, C López, G Fernández, E Murillo, E Villar, L Raya.   

Abstract

OBJECTIVES: To describe the immediate effects of diacutaneous fibrolysis on pain and mobility in patients suffering from painful shoulder, and to assess the ability of the placebo technique to blind participants to group allocation.
DESIGN: A double-blind before-after randomized placebo-controlled pilot study.
SETTING: Two public centres of Primary Health Care of the Spanish National Health System. PARTICIPANTS: Fifty patients (29 women, 21 men) with a diagnosis of painful shoulder of subacromial origin were included. INTERVENTION: Participants were randomly allocated to one of two groups. The intervention group (N = 25) was actually treated with diacutaneous fibrolysis, while the placebo group (N = 25) was treated with placebo diacutaneous fibrolysis. MEASUREMENTS: Active range of motion (flexion, abduction, extension, external and internal rotation) and pain intensity in the hand-behind-back position were measured. Participants were also asked about their perception in terms of comfort of the technique and results obtained.
RESULTS: Between-groups differences were significant in flexion (mean 11.4 degrees; 95% confidence interval (CI) 5.7-17.1), abduction (mean 7.2 degrees; 95% CI 2.0-12.5) and internal rotation movements (mean 3.1 cm; 95% CI 0.1-6.1). There were no significant differences between groups in pain intensity, extension or external rotation movements. The placebo technique showed its ability to blind participants to group allocation. None of the participants suffered any adverse effects from diacutaneous fibrolysis.
CONCLUSION: Diacutaneous fibrolysis may be an effective and safe therapeutic option to improve active range of motion in patients suffering from painful shoulder.

Entities:  

Mesh:

Year:  2010        PMID: 21078700     DOI: 10.1177/0269215510385480

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  5 in total

1.  Effect of diacutaneous fibrolysis on the muscular properties of gastrocnemius muscle.

Authors:  Carlos López-de-Celis; Albert Pérez-Bellmunt; Elena Bueno-Gracia; Pablo Fanlo-Mazas; Carlos Antonio Zárate-Tejero; Luis Llurda-Almuzara; Aida Cadellans Arróniz; Pere Ramón Rodriguez-Rubio
Journal:  PLoS One       Date:  2020-12-09       Impact factor: 3.240

Review 2.  The effectiveness of manual therapy on pain, physical function, and nerve conduction studies in carpal tunnel syndrome patients: a systematic review and meta-analysis.

Authors:  Sandra Jiménez-Del-Barrio; Aida Cadellans-Arróniz; Luis Ceballos-Laita; Elena Estébanez-de-Miguel; Carles López-de-Celis; Elena Bueno-Gracia; Albert Pérez-Bellmunt
Journal:  Int Orthop       Date:  2021-12-03       Impact factor: 3.479

3.  Immediate effects of diacutaneous fibrolysis in athletes with hamstring shortening. A randomized within-participant clinical trial.

Authors:  Aïda Cadellans-Arróniz; Carlos López-de-Celis; Jacobo Rodríguez-Sanz; Albert Pérez-Bellmunt; Noé Labata-Lezáun; Vanessa González-Rueda; Luis Llurda-Almuzara; Pere Ramón Rodríguez-Rubio
Journal:  PLoS One       Date:  2022-07-05       Impact factor: 3.752

4.  Diacutaneous Fibrolysis Intervention in Patients with Mild to Moderate Carpal Tunnel Syndrome May Avoid Severe Cases in Elderly: A Randomized Controlled Trial.

Authors:  Sandra Jiménez-Del-Barrio; Luis Ceballos-Laita; Elena Bueno-Gracia; Sonia Rodríguez-Marco; Santos Caudevilla-Polo; Elena Estébanez-de-Miguel
Journal:  Int J Environ Res Public Health       Date:  2022-09-02       Impact factor: 4.614

5.  Effects of Diacutaneous Fibrolysis on Passive Neuromuscular Response and Mechanosensitivity in Athletes with Hamstring Shortening: A Randomized Controlled Trial.

Authors:  Aida Cadellans-Arróniz; Carlos López-de-Celis; Albert Pérez-Bellmunt; Jacobo Rodríguez-Sanz; Luis Llurda-Almuzara; Vanessa González-Rueda; Pere Ramón Rodríguez-Rubio
Journal:  Int J Environ Res Public Health       Date:  2021-06-18       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.